Functional dissection of the Clostridium botulinum type B hemagglutinin complex: Identification of the carbohydrate and E-cadherin binding sites

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Sugawara, Yo ^a   Yutani, Masahiro ^a   Amatsu, Sho ^a   Matsumura, Takuhiro ^a   Fujinaga, Yukako ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN B; GALACTOSE; HEMAGGLUTININ; HEMAGGLUTININ A1; HEMAGGLUTININ A3; SIALIC ACID; UNCLASSIFIED DRUG; UVOMORULIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BOTULINUM TOXIN; CADHERIN; CARBOHYDRATE; CDH1 PROTEIN, HUMAN; MUCIN; PROTEIN BINDING;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AND RELATED PHENOMENA; BINDING SITE; CARBOHYDRATE BINDING; CLOSTRIDIUM BOTULINUM TYPE B; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN BINDING; BOTULISM; CACO 2 CELL LINE; CHEMISTRY; IMPEDANCE; INTESTINE; INTESTINE ABSORPTION; MICROBIOLOGY; PLASMID;

CLOSTRIDIUM BOTULINUM;

BINDING SITES; BOTULINUM TOXINS; BOTULISM; CACO-2 CELLS; CADHERINS; CARBOHYDRATES; CLOSTRIDIUM BOTULINUM TYPE B; ELECTRIC IMPEDANCE; HEMAGGLUTININS; HUMANS; INTESTINAL ABSORPTION; INTESTINES; MUCINS; NEUROTRANSMITTER AGENTS; PLASMIDS; PROTEIN BINDING;

EID: 84908584357     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111170     Document Type: Article

References (30)

1. Poulain B, Popoff MR, Molgo J (2008) How do the Botulinum Neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action. The Botulinum J 1: 14-87.
2. Barash JR, Arnon SS (2014) A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins. J Infect Dis 209: 183-191.
3. Johnson EA (2014) Validity of Botulinum Neurotoxin Serotype H. J Infect Dis 210: 992-993.
4. Oguma K, Inoue K, Fujinaga Y, Yokota K, Watanabe T, et al. (1999) Structure and function of Clostridium botulinum progenitor toxin. J. Toxicol-Toxin Reviews 18: 17-34.
5. Inoue K, Fujinaga Y, Watanabe T, Ohyama T, Takeshi K, et al. (1996) Molecular composition of Clostridium botulinum type A progenitor toxins. Infect Immun 64: 1589-1594.
6. Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80: 717-766.
7. Simpson LL (2004) Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 44: 167-193.
8. Sakaguchi G (1982) Clostridium botulinum toxins. Pharmacol Ther 19: 165-194.
9. Sugii S, Ohishi I, Sakaguchi G (1977) Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect Immun 16: 910-914.
10. Benefield DA, Dessain SK, Shine N, Ohi MD, Lacy DB (2013) Molecular assembly of botulinum neurotoxin progenitor complexes. Proc Natl Acad Sci U S A 110: 5630-5635.
11. Fujinaga Y, Inoue K, Watanabe S, Yokota K, Hirai Y, et al. (1997) The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. Microbiology 143: 3841-3847.
12. Fujinaga Y, Inoue K, Nomura T, Sasaki J, Marvaud JC, et al. (2000) Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes. FEBS Lett 467: 179-183.
13. Lee K, Gu S, Jin L, Le TT, Cheng LW, et al. (2013) Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog 9: e1003690.
14. Matsumura T, Jin Y, Kabumoto Y, Takegahara Y, Oguma K, et al. (2008) The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell Microbiol 10: 355-364.
15. Sugawara Y, Matsumura T, Takegahara Y, Jin Y, Tsukasaki Y, et al. (2010) Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. J Cell Biol 189: 691-700.
16. Fujinaga Y, Sugawara Y, Matsumura T (2013) Uptake of botulinum neurotoxin in the intestine. Curr Top Microbiol Immunol 364: 45-59.
17. Hasegawa K, Watanabe T, Suzuki T, Yamano A, Oikawa T, et al. (2007) A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms. J Biol Chem 282: 24777-24783.
18. Amatsu S, Sugawara Y, Matsumura T, Kitadokoro K, Fujinaga Y (2013) Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex. J Biol Chem 288: 35617-35625.
19. Arimitsu H, Sakaguchi Y, Lee JC, Ochi S, Tsukamoto K, et al. (2008) Molecular properties of each subcomponent in Clostridium botulinum type B haemagglutinin complex. Microb Pathog 45: 142-149.
20. Inoue K, Sobhany M, Transue TR, Oguma K, Pedersen LC, et al. (2003) Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum. Microbiology 149: 3361-3370.
21. Fujinaga Y, Inoue K, Watarai S, Sakaguchi Y, Arimitsu H, et al. (2004) Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes. Microbiology 150: 1529-1538.
22. Nakamura T, Tonozuka T, Ide A, Yuzawa T, Oguma K, et al. (2008) Sugar-binding sites of the HA1 subcomponent of Clostridium botulinum type C progenitor toxin. J Mol Biol 376: 854-867.
23. Jin Y, Takegahara Y, Sugawara Y, Matsumura T, Fujinaga Y (2009) Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology 155: 35-45.
24. Yamashita S, Yoshida H, Uchiyama N, Nakakita Y, Nakakita S, et al. (2012) Carbohydrate recognition mechanism of HA70 from Clostridium botulinum deduced from X-ray structures in complexes with sialylated oligosaccharides. FEBS Lett 586: 2404-2410.
25. Lee K, Lam KH, Kruel AM, Perry K, Rummel A, et al. (2014) High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex. Biochem Biophys Res Commun 446: 568-573.
26. Nakamura T, Takada N, Tonozuka T, Sakano Y, Oguma K, et al. (2007) Binding properties of Clostridium botulinum type C progenitor toxin to mucins. Biochim Biophys Acta 1770: 551-555.
27. Pinho SS, Seruca R, Gärtner F, Yamaguchi Y, Gu J, et al. (2011) Modulation of E-cadherin function and dysfunction by N-glycosylation. Cell Mol Life Sci 68: 1011-1020.
28. Harrison OJ, Jin X, Hong S, Bahna F, Ahlsen G, et al. (2011) The extracellular architecture of adherens junctions revealed by crystal structures of type I cadherins. Structure 19: 244-256.
29. Lommel M, Winterhalter PR, Willer T, Dahlhoff M, Schneider MR, et al. (2013) Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. Proc Natl Acad Sci U S A 110: 21024-21029.
30. Lee K, Zhong X, Gu S, Kruel AM, Dorner MB, et al. (2014) Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344: 1405-1410.